I am holding a position in the medical imaging industry’s median technologies as a senior data scientist. my job combines cutting edge technology, management, international traveling and is patent oriented. I ve started my training in a lab in Lyon, France, under Pr. Berthezene supervision where I used iron oxide nanoparticles (USPIO) as contrast agents for MRI to assess the extent and severity of stroke in a stoke-induced mice model on Bruckers 4.7T and 7T. During this work I have also implement a specific sequence on both machines to image iron load macrophages with positive contrast image in the brain. Then, I joined the lab of Dr. Ross at the University of Michigan to diversify my expertise on cancer and imaging. I have applied post-processing technique to MRI and CT quantitative datasets to assess early changes in tumor burden and bone turnover following a therapeutic intervention. More importantly, I have learned the mechanisms to develop, to patent and to use a technology in a research/core environment. To complete my profile with a clinical experience, I joined Pr. Ge’s lab at New York University. I had leaded projects with direct applications on MS and NMO follows up/detection under hypercapnia challenge at 3T and high resolution MRI at 7T. I have also investigated SWI and QSM for the detection and characterization of the MS-NMO plaques/Alzheimer, applied post processing technique to broke the diffraction limit of the acquisition and make substantial work on developing the next generation of microvascular imaging with USPIO injection. Ilback in France, I use to work as a project manager for a nationwide cohort in MS, in collaboration with Pr Cotton. This activity consists on collecting clinical MRI data from 25 expert centers on MS nationwide. I have also continually been a reviewer for prestigious review such as AJNR, European radiology, European journal of radiology.. (publons #991094) as well as international meeting ISMRM, WMI..
Listed skills include Mri, In Vivo, Image Analysis, Neuroimaging, and 46 others.